Acuitive Technologies
-
Biologics
Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
ALLENDALE, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Acuitive Technologies, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market CITREPORE, a…
Read More » -
Biologics
Two Industry Veterans Join Acuitive Technologies, Inc. Board of Directors as Independent Members
ALLENDALE, N.J., March 13, 2023 (GLOBE NEWSWIRE) — Acuitive Technologies announced that Vince Forlenza and Gary Fischetti will join their…
Read More » -
Extremities
Acuitive Technologies Granted FDA 510(k) Clearance for CITREFIX™ Knotless Suture Anchor
ALLENDALE, N.J., Feb. 11, 2021 /PRNewswire/ — Acuitive Technologies today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the…
Read More » -
Extremities
Acuitive Technologies Granted FDA 510(k) Clearance for CITREGEN™ CITRELOCK™ Tendon Interference Screw System
ALLENDALE, N.J., Oct. 21, 2020 /PRNewswire/ — Acuitive Technologies today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the CITRELOCK™ Interference Screw System…
Read More »